Showing 1221-1230 of 3885 results for "".
New Drugs for Treating Fungal Infections
https://practicaldermatology.com/topics/general-topics/new-drugs-for-treating-fungal-infections/21426/A review of recent developments for efficacious treatment.Recent Developments
https://practicaldermatology.com/topics/practice-management/recent-developments-49/24006/Currents: Patient Engagement And Adherence
https://practicaldermatology.com/topics/practice-management/currents-patient-engagement-and-adherence/23500/New Therapeutic Options for the Treatment of Psoriatic Arthritis: IL-17 Blockers
https://practicaldermatology.com/topics/psoriasis/new-therapeutic-options-for-the-treatment-of-psoriatic-arthritis-il-17-blockers/20447/Are TNF inhibitors still the gold standard for PsA?Flower Power: Inside Growing Interest in Topical Botanicals
https://practicaldermatology.com/topics/practice-management/flower-power-inside-growing-interest-in-topical-botanicals/20524/Botanicals are cropping up in growing numbers of skincare products. Are you ready to field patient questions?New Products
https://practicaldermatology.com/columns/new-products/new-products/20668/The Heart of the Matter
https://practicaldermatology.com/topics/psoriasis/the-heart-of-the-matter/21043/American heart month—celebrated in February—calls attention to link between psoriasis and CV disease.Currents
https://practicaldermatology.com/topics/practice-management/currents/21161/Clinical Case Report: Severe Allergic Contact Dermatitis of Eyelids: When Topical and Oral Steroids Are Not an Option
https://practicaldermatology.com/topics/general-topics/clinical-case-report-severe-allergic-contact-dermatitis-of-eyelids-when-topical-and-oral-steroids-are-not-an-option/21878/Topical calcineurin inhibitors may present a therapeutic option for contact dermatitis of the eyelids.TNF Inhibitors and the Risk of Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tnf-inhibitors-and-the-risk-of-melanoma/21519/New research offers a deeper look into the potential elevated risk for malignant melanoma from TNF treatment.